Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts-Medco Deal Fits Post-Health Reform Realities, But Was Hastened By Contract Losses

This article was originally published in The Pink Sheet Daily

Executive Summary

Timing of merger announcement surprises industry observers but follows Medco's loss of a major long-term PBM contract with UnitedHealth.

You may also be interested in...



Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca

Medco Health Solutions and AstraZeneca have received subpoenas from the DoJ for information involving arrangements pertaining to four AstraZeneca drugs.

Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca

Medco Health Solutions and AstraZeneca have received subpoenas from the DoJ for information involving arrangements pertaining to four AstraZeneca drugs.

FTC Review Of Express Scripts/Medco Merger Is First Integration Challenge

The proposed merger of two of the three major pharmacy benefit managers may have tough time clearing FTC; the agency has rejected other deals that would have left only two dominant players in a sector.

Topics

UsernamePublicRestriction

Register

MT142313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel